(Q67267094)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2104808%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

title

Long-term suppression of ovarian function by a luteinizing-hormone releasing hormone agonist implant in patients with endometriosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2104808%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference

H M Fraser

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2104808%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

J Sandow

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2104808%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

G M Cowen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2104808%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

M A Lumsden

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2104808%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

R Haining

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2104808%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

S K Smith

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2104808%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

language of work or name

English

0 references

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2104808%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2104808%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2104808%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2104808%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

page(s)

61-68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2104808%20AND%20SRC:MED&resulttype=core&format=json

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

11 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

Serum concentration and urinary excretion of the luteinizing hormone-releasing hormone agonist buserelin in patients with endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

Revised American Fertility Society classification of endometriosis: 1985

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

The radioimmunoassay of pregnanediol-3α-glucuronide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

The radioimmunoassay of steroid glucuronides. The oestrogen C-3 glucuronides as haptens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

A rapid luteinizing hormone radioimmunoassay for the prediction of ovulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

Comparison of single and repeated applications of a long-acting synthetic analogue of LHRH [D-Ser (TBU)6 EA10 LHRH] in the assessment of pituitary gonadotrophin secretory capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

Antibody production against an agonist analogue of luteinizing hormone-releasing hormone: evaluation of immunochemical and physiological consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

Reduction in pituitary desensitization and prolongation of gonadotropin release by estrogen during continuous administration of gonadotropin-releasing hormone in women: its antagonism by progesterone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

Down-regulation of pituitary gonadotropin secretion in postmenopausal females by continuous gonadotropin-releasing hormone administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

Gonadotropin-releasing hormone desensitization preferentially inhibits expression of the luteinizing hormone beta-subunit gene in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

inferred from DOI database lookup

7 January 2021

based on heuristic

An implant of a gonadotropin releasing hormone agonist (buserelin) which suppresses ovarian function in the macaque for 3-5 months

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953217-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(16)53217-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2104808%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference